Completed NA INTERVENTIONAL 2-arm NCT01797991

Comparison of Two Regimens of Dexamethasone in the Prevention of Hypersensitivity Reactions to Paclitaxel, a Pilot Study (DEXEL-RH)

Étude Pilote DEXEL-RH: Comparaison de Deux schémas Posologiques de DEXaméthasone en prévention Des Réactions d'Hypersensibilité au paclitaXEL

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Conditions Prevention of Hypersensitivity Reactions to Paclitaxel

Interventions Dexamethasone IV Dexamethasone per os Matching placebo for dexamethasone IV Matching placebo for dexamethasone per os

Updated 5 times since 2017 Last updated: Oct 29, 2013 Started: Feb 28, 2013 Primary completion: Aug 31, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Prevention of Hypersensitivity Reactions to Paclitaxel, this trial is completed. The trial is conducted by Centre hospitalier de l'Université de Montréal (CHUM) and has accumulated 5 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre hospitalier de l'Université de Montréal (CHUM)

Data source: Centre hospitalier de l'Université de Montréal (CHUM)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada